Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin

Chiharu Yokoyama; Takuma Aoyama; Takahiro Ido; Akemi Kakino; Takeru Shiraki; Toshiki Tanaka; Kazuhiko Nishigaki; Aiko Hasegawa; Yoshiko Fujita; Tatsuya Sawamura; Shinya Minatoguchi

doi:10.1371/journal.pone.0154994

Loading metrics

Open Access

Peer-reviewed

Research Article

Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin

Chiharu Yokoyama,

Affiliation Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
⨯
Takuma Aoyama ,

* E-mail: tkmaoyama@aol.com

Affiliations Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan, Cardiovascular Center, Kizawa Memorial Hospital, Minokamo, Japan
⨯
Takahiro Ido,

Affiliations Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan, Cardiovascular Center, Kizawa Memorial Hospital, Minokamo, Japan
⨯
Akemi Kakino,

Affiliations Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan, Department of Physiology, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Takeru Shiraki,

Affiliation Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
⨯
Toshiki Tanaka,

Affiliation Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
⨯
Kazuhiko Nishigaki,

Affiliation Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
⨯
Aiko Hasegawa,

Affiliation Department of Physiology, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Yoshiko Fujita,

Affiliation Department of Physiology, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Tatsuya Sawamura,

Affiliations Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan, Department of Physiology, Shinshu University School of Medicine, Matsumoto, Japan
⨯
Shinya Minatoguchi

Affiliation Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
⨯

Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin

Chiharu Yokoyama,
Takuma Aoyama,
Takahiro Ido,
Akemi Kakino,
Takeru Shiraki,
Toshiki Tanaka,
Kazuhiko Nishigaki,
Aiko Hasegawa,
Yoshiko Fujita,
Tatsuya Sawamura

Published: May 19, 2016
https://doi.org/10.1371/journal.pone.0154994

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Heart
Is the Subject Area "Heart" applicable to this article?

Thanks for your feedback.
Cardiomyocytes
Is the Subject Area "Cardiomyocytes" applicable to this article?

Thanks for your feedback.
Cardiomyopathies
Is the Subject Area "Cardiomyopathies" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Fibroblasts
Is the Subject Area "Fibroblasts" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
White blood cells
Is the Subject Area "White blood cells" applicable to this article?

Thanks for your feedback.